Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 80,137 | 79,047 | 79,790 | 89,690 | 75,543 |
| Cost of Goods | 44,885 | 46,660 | 48,887 | 55,001 | 46,283 |
| Gross Profit | 35,252 | 32,387 | 30,903 | 34,689 | 29,260 |
| Operating Expenses | 33,733 | 32,074 | 34,962 | 33,145 | 26,993 |
| Operating Income | 2,404 | 973 | -3,172 | 1,545 | 2,550 |
| Interest Expense | 22 | 24 | 30 | 1 | 124 |
| Other Income | -800 | 60,144 | -431 | -955 | 148 |
| Pre-tax Income | 1,582 | 61,093 | -3,633 | 589 | 2,574 |
| Income Tax | 598 | 14,173 | -1,479 | -1,129 | 958 |
| Net Income Continuous | 984 | 46,920 | -2,154 | 1,718 | 1,616 |
| Minority Interests | -326 | -867 | -3,022 | -149 | -773 |
| Net Income | $1,310 | $47,787 | $868 | $1,867 | $2,389 |
| EPS Basic Total Ops | 0.03 | 1.01 | 0.02 | 0.04 | 0.05 |
| EPS Basic Continuous Ops | 0.02 | 1.00 | -0.05 | 0.04 | 0.03 |
| EPS Diluted Total Ops | 0.03 | 0.96 | 0.02 | 0.04 | 0.05 |
| EPS Diluted Continuous Ops | 0.02 | 0.94 | -0.04 | 0.04 | 0.03 |
| EBITDA(a) | $6,871 | $5,382 | $1,256 | $5,925 | $6,722 |